All Stories

  1. Association of Fetal Gene Regulatory Gene Deletions With Poor Cognition in Schizophrenia and Community-Based Samples
  2. Structural Genetic Variations Illuminate the Dimensional Landscape of Child Psychopathology and Cognition
  3. Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction
  4. Negative Symptom Trajectories in Individuals at Clinical High-Risk for Psychosis: Differences Based on Deficit Syndrome, Persistence, and Transition Status
  5. Editorial: New Clues Into Cortical Changes That Converge on Psychosis
  6. Associations between acute and chronic lifetime stressors and psychosis-risk symptoms in individuals with 22q11.2 copy number variants
  7. Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk
  8. Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis
  9. A genetics-first approach to understanding autism and schizophrenia spectrum disorders: the 22q11.2 deletion syndrome
  10. Editorial: Psychotic-like Experiences: Bolstering Protective Factors in Marginalized Youth
  11. Local molecular and global connectomic contributions to cross-disorder cortical abnormalities
  12. Copy number variation at the 22q11.2 locus influences prevalence, severity, and psychiatric impact of sleep disturbance
  13. The Association Between Neighborhood Poverty and Hippocampal Volume Among Individuals at Clinical High-Risk for Psychosis: The Moderating Role of Social Engagement
  14. Cross disorder comparisons of brain structure in schizophrenia, bipolar disorder, major depressive disorder, and 22q11.2 deletion syndrome: A review of ENIGMA findings
  15. Molecular and connectomic vulnerability shape cross-disorder cortical abnormalities
  16. Confident memory errors and disrupted reality testing in early psychosis
  17. Copy Number Variation at the 22q11.2 Locus Influences Prevalence, Severity, and Psychiatric Impact of Sleep Disturbance
  18. The prediction-error hypothesis of schizophrenia: new data point to circuit-specific changes in dopamine activity
  19. Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis
  20. A normative chart for cognitive development in a genetically selected population
  21. Risk and Resilience in Extraordinary Times
  22. Neurobehavioral dimensions of Prader Willi Syndrome: Relationships between sleep disturbance and psychotic experiences
  23. Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium
  24. Intelligence, educational attainment, and brain structure in those at familial high‐risk for schizophrenia or bipolar disorder
  25. Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis.
  26. Psychosis Risk and Development: What Do We Know From Population-Based Studies?
  27. Reciprocal Copy Number Variations at 22q11.2 Produce Distinct and Convergent Neurobehavioral Impairments Relevant for Schizophrenia and Autism Spectrum Disorder
  28. Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness
  29. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort
  30. Applying a Transdiagnostic Cognitive-Behavioral Treatment to Adolescents at High Risk for Serious Mental Illness: Rationale and Preliminary Findings
  31. Contribution of common and rare variants to bipolar disorder susceptibility in extended pedigrees from population isolates
  32. Extensions of Multiple-Group Item Response Theory Alignment: Application to Psychiatric Phenotypes in an International Genomics Consortium
  33. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion
  34. Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains
  35. Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk
  36. Duration of the psychosis prodrome
  37. Predictive validity of conversion from the clinical high risk syndrome to frank psychosis
  38. Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis
  39. Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator
  40. Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart Defects
  41. Synaptic and Gene Regulatory Mechanisms in Schizophrenia, Autism, and 22q11.2 Copy Number Variant–Mediated Risk for Neuropsychiatric Disorders
  42. Genetic analysis of activity, brain and behavioral associations in extended families with heavy genetic loading for bipolar disorder
  43. Sleep problems and attenuated psychotic symptoms in youth at clinical high-risk for psychosis
  44. Correction to: Mechanisms underlying the EEG biomarker in Dup15q syndrome
  45. Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome
  46. Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis
  47. Structural Brain Alterations in Youth With Psychosis and Bipolar Spectrum Symptoms
  48. Accelerating the Bending Arc Toward Equality: A Commentary on Gender Trends in Authorship in Psychiatry Journals
  49. The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder
  50. A framework for the investigation of rare genetic disorders in neuropsychiatry
  51. Altered white matter microstructure in 22q11.2 deletion syndrome: a multisite diffusion tensor imaging study
  52. Mechanisms underlying the EEG biomarker in Dup15q syndrome
  53. State-Dependent Functional Dysconnectivity in Youth With Psychosis Spectrum Symptoms
  54. Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study
  55. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services
  56. The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning
  57. Disruptions in White Matter Maturation and Mediation of Cognitive Development in Youths on the Psychosis Spectrum
  58. Stress perception following childhood adversity: Unique associations with adversity type and sex
  59. Systems Analysis of the 22q11.2 Microdeletion Syndrome Converges on a Mitochondrial Interactome Necessary for Synapse Function and Behavior
  60. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis
  61. Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis
  62. Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium
  63. Neurocognitive profiles in the prodrome to psychosis in NAPLS-1
  64. Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia
  65. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort
  66. Reduced higher dimensional temporal dynamism in neurofibromatosis type 1
  67. Alternative diffusion anisotropy measures for the investigation of white matter alterations in 22q11.2 deletion syndrome
  68. The many roads to psychosis: recent advances in understanding risk and mechanisms
  69. Dissociable Disruptions in Thalamic and Hippocampal Resting-State Functional Connectivity in Youth with 22q11.2 Deletions
  70. Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study
  71. Understanding the Hidden Complexity of Latin American Population Isolates
  72. Tobacco use and psychosis risk in persons at clinical high risk
  73. The Global Functioning: Social and Role Scales—Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis
  74. Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects
  75. The Neuroanatomy of Autism Spectrum Disorder Symptomatology in 22q11.2 Deletion Syndrome
  76. Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization
  77. Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk
  78. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis
  79. Retraction Notice to: Nested Inversion Polymorphisms Predispose Chromosome 22q11.2 to Meiotic Rearrangements
  80. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk
  81. Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome
  82. Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome
  83. The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning
  84. The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis
  85. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size
  86. Networks of blood proteins in the neuroimmunology of schizophrenia
  87. Exploration of clinical high-risk dropouts
  88. Erratum
  89. Enhanced switching and familial susceptibility for psychosis
  90. Toward Leveraging Human Connectomic Data in Large Consortia: Generalizability of fMRI-Based Brain Graphs Across Sites, Sessions, and Paradigms
  91. Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort
  92. Getting Off Tract: Developmental Disruptions of White Matter in Youth With Bipolar Disorder
  93. Prediction of psychosis across protocols and risk cohorts using automated language analysis
  94. Deletion size analysis of 1680 22q11.2DS subjects identifies a new recombination hotspot on chromosome 22q11.2
  95. Connectivity-enhanced diffusion analysis reveals white matter density disruptions in first episode and chronic schizophrenia
  96. Comorbid diagnoses for youth at clinical high risk of psychosis
  97. Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety
  98. Reciprocal Disruptions in Thalamic and Hippocampal Resting-State Functional Connectivity in Youth with 22q11.2 Deletions
  99. Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome
  100. Cognitive genomics: Searching for the genetic roots of neuropsychological functioning.
  101. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis
  102. RETRACTED: Nested Inversion Polymorphisms Predispose Chromosome 22q11.2 to Meiotic Rearrangements
  103. Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the GPR98 Locus on 5q14.3
  104. Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups
  105. The role of a family history of psychosis for youth at clinical high risk of psychosis
  106. Disrupted Working Memory Circuitry in Adolescent Psychosis
  107. Changes in symptom content from a clinical high‐risk state to conversion to psychosis
  108. A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium
  109. Enhancing the Informativeness and Replicability of Imaging Genomics Studies
  110. Episodic Memory for Dynamic Social Interaction Across Phase of Illness in Schizophrenia
  111. Mapping 22q11.2 Gene Dosage Effects on Brain Morphometry
  112. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group
  113. Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis
  114. Intrinsic Connectivity Network-Based Classification and Detection of Psychotic Symptoms in Youth With 22q11.2 Deletions
  115. Emerging Global Initiatives in Neurogenetics: The Enhancing Neuroimaging Genetics through Meta-analysis (ENIGMA) Consortium
  116. Risky Decision Making in Neurofibromatosis Type 1: An Exploratory Study
  117. Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study
  118. The Role of microRNA Expression in Cortical Development During Conversion to Psychosis
  119. Increased hippocampal, thalamus and amygdala volume in long-term lithium-treated bipolar I disorder patients compared with unmedicated patients and healthy subjects
  120. Multisite reliability of MR-based functional connectivity
  121. Reverse Pathway Genetic Approach Identifies Epistasis in Autism Spectrum Disorders
  122. Categorical Versus Dimensional Approaches to Autism-Associated Intermediate Phenotypes in 22q11.2 Microdeletion Syndrome
  123. ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide
  124. Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity
  125. Insights into psychosis risk from leukocyte microRNA expression
  126. Association of Neurocognition With Transition to Psychosis
  127. Hippocampal volume in subjects at clinical high-risk for psychosis: A systematic review and meta-analysis
  128. Biotypes: The Tip of the Research Domain Criteria Iceberg
  129. Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort
  130. An Individualized Risk Calculator for Research in Prodromal Psychosis
  131. Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis
  132. The Violent Content in Attenuated Psychotic Symptoms
  133. Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research
  134. Errors in Identification of 17 of 527 Brain Images in Genetic Study of Phenotypes Associated With Bipolar Disorder
  135. Traumatic brain injury in individuals at clinical high risk for psychosis
  136. Characterization of Expression Quantitative Trait Loci in Pedigrees from Colombia and Costa Rica Ascertained for Bipolar Disorder
  137. Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis
  138. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers
  139. The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis
  140. Early interventions in risk groups for schizophrenia: what are we waiting for?
  141. Electrophysiological Endophenotypes for Schizophrenia
  142. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort
  143. A randomized placebo‐controlled lovastatin trial for neurobehavioral function in neurofibromatosis I
  144. Subcortical volumetric abnormalities in bipolar disorder
  145. Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis
  146. Atypical functional connectivity in resting-state networks of individuals with 22q11.2 deletion syndrome: associations with neurocognitive and psychiatric functioning
  147. Rare copy number variants and congenital heart defects in the 22q11.2 deletion syndrome
  148. Genetic contributions to circadian activity rhythm and sleep pattern phenotypes in pedigrees segregating for severe bipolar disorder
  149. High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls
  150. Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis
  151. Severity of thought disorder predicts psychosis in persons at clinical high-risk
  152. Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis
  153. Anxiety in youth at clinical high risk for psychosis
  154. Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk
  155. Theory of mind, emotion recognition and social perception in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort
  156. Resting state functional MRI reveals abnormal network connectivity in neurofibromatosis 1
  157. Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis
  158. Demographic correlates of attenuated positive psychotic symptoms
  159. Transcriptome Profiling of Peripheral Blood in 22q11.2 Deletion Syndrome Reveals Functional Pathways Related to Psychosis and Autism Spectrum Disorder
  160. Brain structure–function associations in multi-generational families genetically enriched for bipolar disorder
  161. Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome
  162. North American Prodrome Longitudinal Study (NAPLS 2)
  163. Core Schemas in Youth at Clinical High Risk for Psychosis
  164. Cognitive Decline Preceding the Onset of Psychosis in Patients With 22q11.2 Deletion Syndrome
  165. Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study
  166. Substance use in individuals at clinical high risk of psychosis
  167. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
  168. Neural mechanisms of response inhibition and impulsivity in 22q11.2 deletion carriers and idiopathic attention deficit hyperactivity disorder
  169. Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk
  170. Stress exposure and sensitivity in the clinical high-risk syndrome: Initial findings from the North American Prodrome Longitudinal Study (NAPLS)
  171. Altered white matter microstructure is associated with social cognition and psychotic symptoms in 22q11.2 microdeletion syndrome
  172. Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project
  173. Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: Analysis from the North American Prodrome Longitudinal Study
  174. Time Reproduction Performance Is Associated With Age and Working Memory in High-Functioning Youth With Autism Spectrum Disorder
  175. Psychiatric Disorders From Childhood to Adulthood in 22q11.2 Deletion Syndrome: Results From the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome
  176. Contributions of Feature Binding During Encoding and Functional Connectivity of the Medial Temporal Lobe Structures to Episodic Memory Deficits Across the Prodromal and First-Episode Phases of Schizophrenia
  177. Multisystem Component Phenotypes of Bipolar Disorder for Genetic Investigations of Extended Pedigrees
  178. The 22q11.2 Deletion Syndrome as a Window into Complex Neuropsychiatric Disorders Over the Lifespan
  179. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium
  180. Perceptions of family criticism and warmth and their link to symptom expression in racially/ethnically diverse adolescents and young adults at clinical high risk for psychosis
  181. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data
  182. Altered relationships between age and functional brain activation in adolescents at clinical high risk for psychosis
  183. Disrupted working memory circuitry and psychotic symptoms in 22q11.2 deletion syndrome
  184. Reciprocal social behavior in youths with psychotic illness and those at clinical high risk
  185. Neural Substrates of Inhibitory Control Deficits in 22q11.2 Deletion Syndrome†
  186. Autism traits in the RASopathies
  187. Youth-caregiver Agreement on Clinical High-risk Symptoms of Psychosis
  188. Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis
  189. Default mode network connectivity and reciprocal social behavior in 22q11.2 deletion syndrome
  190. Psychotropic medication use in youth at high risk for psychosis: Comparison of baseline data from two research cohorts 1998–2005 and 2008–2011
  191. Converging levels of analysis on a genomic hotspot for psychosis: Insights from 22q11.2 Deletion Syndrome
  192. Enhanced Maternal Origin of the 22q11.2 Deletion in Velocardiofacial and DiGeorge Syndromes
  193. Enhanced Maternal Origin of the 22q11.2 Deletion in Velocardiofacial and DiGeorge Syndromes
  194. Three-dimensional mapping of hippocampal and amygdalar structure in euthymic adults with bipolar disorder not treated with lithium
  195. Structural abnormalities in cortical volume, thickness, and surface area in 22q11.2 microdeletion syndrome: Relationship with psychotic symptoms
  196. Corrigendum to “The Learning Disabilities Network (LeaDNet): Using Neurofibromatosis Type 1 [NF1] as a Paradigm for Translational Research”
  197. Social cognition in 22q11.2 microdeletion syndrome: Relevance to psychosis?
  198. Coping styles of individuals at clinical high risk for developing psychosis
  199. Alterations in White Matter Microstructure in Neurofibromatosis-1
  200. Deficits in Mental State Attributions in Individuals with 22q11.2 Deletion Syndrome (Velo-Cardio-Facial Syndrome)
  201. The Learning Disabilities Network (LeaDNet): Using neurofibromatosis type 1 (NF1) as a paradigm for translational research
  202. Trait impulsivity as an endophenotype for bipolar I disorder
  203. The Voices Go, But the Song Remains the Same: How Can We Rescue Cognition in Early-Onset Schizophrenia?
  204. Erratum to: Processing Speed and Neurodevelopment in Adolescent-Onset Psychosis: Cognitive Slowing Predicts Social Function
  205. Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: A preliminary study
  206. Processing Speed and Neurodevelopment in Adolescent-Onset Psychosis: Cognitive Slowing Predicts Social Function
  207. Genetic influence on the working memory circuitry: Behavior, structure, function and extensions to illness
  208. Genetic Architecture of Declarative Memory
  209. Recovery From an At-Risk State: Clinical and Functional Outcomes of Putatively Prodromal Youth Who Do Not Develop Psychosis
  210. Abnormal movements are associated with poor psychosocial functioning in adolescents at high risk for psychosis
  211. Thought Disorder and Communication Deviance as Predictors of Outcome in Youth at Clinical High Risk for Psychosis
  212. Psychosis risk screening with the Prodromal Questionnaire — Brief Version (PQ-B)
  213. Response to the Letter to the Editor: “Clinical symptoms and neurocognitive performance: potential impact of substance use”
  214. The impact of neurocognitive impairment on occupational recovery of clinically stable patients with bipolar disorder: a prospective study
  215. Common genetic influences on depression, alcohol, and substance use disorders in Mexican-American families
  216. Clinical and Genetic High-Risk Paradigms: Converging Paths to Psychosis Meet in the Temporal Lobes
  217. Response to De Nadai Letter
  218. Hippocampal morphology in lithium and non-lithium-treated bipolar I disorder patients, non-bipolar co-twins, and control twins
  219. Mapping Corpus Callosum Morphology in Twin Pairs Discordant for Bipolar Disorder
  220. Social Cognition in Schizophrenia, Part 1: Performance Across Phase of Illness
  221. Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal study
  222. Prefrontal and paralimbic metabolic dysregulation related to sustained attention in euthymic older adults with bipolar disorder
  223. Striatal volumes and dyskinetic movements in youth at high-risk for psychosis
  224. Neurocognitive and Neuroimaging Predictors of Clinical Outcome in Bipolar Disorder
  225. Identification and Treatment of a Pineal Region Tumor in an Adolescent With Prodromal Psychotic Symptoms
  226. Neurofibromin regulates corticostriatal inhibitory networks during working memory performance
  227. Markers of Basal Ganglia Dysfunction and Conversion to Psychosis: Neurocognitive Deficits and Dyskinesias in the Prodromal Period
  228. The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC)
  229. Neuropsychology of the Prodrome to Psychosis in the NAPLS Consortium<subtitle>Relationship to Family History and Conversion to Psychosis</subtitle><alt-title>Neuropsychology of Prodrome to Psychosis</alt-title>
  230. Predicting the longitudinal effects of the family environment on prodromal symptoms and functioning in patients at-risk for psychosis
  231. Integrity of emotional and motivational states during the prodromal, first-episode, and chronic phases of schizophrenia.
  232. Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis
  233. Fronto-temporal dysregulation in asymptomatic bipolar I patients: A paired associate functional MRI study
  234. Elucidating a Magnetic Resonance Imaging-Based Neuroanatomic Biomarker for Psychosis: Classification Analysis Using Probabilistic Brain Atlas and Machine Learning Algorithms
  235. Altered Hippocampal Morphology in Unmedicated Patients with Major Depressive Illness
  236. Paternal age as a risk factor for schizophrenia: How important is it?
  237. Symptomatic and functional correlates of regional brain physiology during working memory processing in patients with recent onset schizophrenia
  238. White Matter Integrity and Prediction of Social and Role Functioning in Subjects at Ultra-High Risk for Psychosis
  239. Impulsivity, risk taking, alcohol abuse, and bipolar disorder: response to Thomas Richardson
  240. Obstetric complications and risk for conversion to psychosis among individuals at high clinical risk
  241. Exploring Predictors of Outcome in the Psychosis Prodrome: Implications for Early Identification and Intervention
  242. Fronto-temporal dysregulation in remitted bipolar patients: an fMRI delayed-non-match-to-sample (DNMS) study
  243. Methodological Issues in Molecular Genetic Studies of Mental Disorders
  244. Obsessive compulsive symptoms in the psychosis prodrome: Correlates of clinical and functional outcome
  245. Re-evaluating dorsolateral prefrontal cortex activation during working memory in schizophrenia
  246. Conceptualizing impulsivity and risk taking in bipolar disorder: importance of history of alcohol abuse
  247. Family problem solving interactions and 6-month symptomatic and functional outcomes in youth at ultra-high risk for psychosis and with recent onset psychotic symptoms: A longitudinal study
  248. Fronto-limbic circuitry in euthymic bipolar disorder: Evidence for prefrontal hyperactivation
  249. Parent attitudes and parent adolescent interaction in families of youth at risk for psychosis and with recent-onset psychotic symptoms
  250. Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder
  251. Neural phenotypes of common and rare genetic variants
  252. Alterations in Midline Cortical Thickness and Gyrification Patterns Mapped in Children with 22q11.2 Deletions
  253. Three-Dimensional Mapping of Hippocampal Anatomy in Adolescents With Bipolar Disorder
  254. Diffusion Tensor Imaging of the Superior Longitudinal Fasciculus and Working Memory in Recent-Onset Schizophrenia
  255. Remember and know judgments during recognition in chronic schizophrenia
  256. Reply: Lithium and Increased Cortical Gray Matter—More Tissue or More Water?
  257. A collaborative knowledge base for cognitive phenomics
  258. A relationship between neurocognitive impairment and functional impairment in bipolar disorder: A pilot study
  259. The Neurocognitive Signature of Psychotic Bipolar Disorder
  260. Three-Dimensional Mapping of Hippocampal Anatomy in Unmedicated and Lithium-Treated Patients with Bipolar Disorder
  261. Ecological assessment of executive dysfunction in the psychosis prodrome: A pilot study
  262. Greater Cortical Gray Matter Density in Lithium-Treated Patients with Bipolar Disorder
  263. Preliminary Findings for Two New Measures of Social and Role Functioning in the Prodromal Phase of Schizophrenia
  264. The Course of Neurocognition and Social Functioning in Individuals at Ultra High Risk for Psychosis
  265. Cortical mapping of genotype–phenotype relationships in schizophrenia
  266. Mapping Cortical Thickness in Children with 22q11.2 Deletions
  267. Endophenotypes for psychiatric disorders: ready for primetime?
  268. Patterns of memory impairment in bipolar disorder and unipolar major depression
  269. Reduced educational attainment in bipolar disorder
  270. Dissociable mechanisms for memory impairment in bipolar disorder and schizophrenia
  271. Neurocognitive performance and functional disability in the psychosis prodrome
  272. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis
  273. Sources of declarative memory impairment in bipolar disorder: Mnemonic processes and clinical features
  274. Positive family environment predicts improvement in symptoms and social functioning among adolescents at imminent risk for onset of psychosis
  275. Declarative memory impairment in pediatric bipolar disorder
  276. A multilevel analysis of cognitive dysfunction and psychopathology associated with chromosome 22q11.2 deletion syndrome in children
  277. Emotional Stroop performance predicts disorganization in schizophrenia
  278. The Psychosis Prodrome in Adolescent Patients Viewed Through the Lens of DSM-IV
  279. Attention deficits in bipolar disorder: a comparison based on the Continuous Performance Test
  280. Effects of Comt Genotype on Behavioral Symptomatology in the 22q11.2 Deletion Syndrome
  281. Beyond hypofrontality: A quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia
  282. Common Substrates of Dysphoria in Stimulant Drug Abuse and Primary Depression: Therapeutic Targets
  283. Visuospatial and Numerical Cognitive Deficits in Children with Chromosome 22Q11.2 Deletion Syndrome
  284. Effects of a Functional COMT Polymorphism on Prefrontal Cognitive Function in Patients With 22q11.2 Deletion Syndrome
  285. Regional Brain Abnormalities in 22q11.2 Deletion Syndrome: Association With Cognitive Abilities and Behavioral Symptoms
  286. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder
  287. Why genetic investigation of psychiatric disorders is so difficult
  288. A Prospective Study of Childhood Neurocognitive Functioning in Schizophrenic Patients and Their Siblings
  289. Early and Late Neurodevelopmental Influences in the Prodrome to Schizophrenia: Contributions of Genes, Environment, and Their Interactions
  290. Catatonia isn't ready for a unified theory
  291. Cognitive development in VCFS
  292. Williams syndrome cognitive profile also characterizes Velocardiofacial/DiGeorge syndrome
  293. The Neurocognitive Phenotype of the 22Q11.2 Deletion Syndrome: Selective Deficit in Visual-Spatial Memory
  294. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review
  295. A Prospective Cohort Study of Childhood Behavioral Deviance and Language Abnormalities as Predictors of Adult Schizophrenia
  296. A Prospective Cohort Study of Genetic and Perinatal Influences in the Etiology of Schizophrenia
  297. Childhood Cognitive Functioning in Schizophrenia Patients and Their Unaffected Siblings: A Prospective Cohort Study
  298. Childhood Neuromotor Dysfunction in Schizophrenia Patients and Their Unaffected Siblings: A Prospective Cohort Study
  299. A prospective cohort study of neurodevelopmental processes in the genesis and epigenesis of schizophrenia
  300. Personality Pathology and Time to Remission in Depressed Outpatients Treated with Interpersonal Psychotherapy
  301. The nightmare: Biological and psychological origins.